Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
Type 2N von Willebrand disease (VWD) is characterized by a markedly decreased affinity of von Willebrand factor (VWF) for factor VIII (FVIII). The FVIII binding site has been localized within the first 272 amino acid residues of mature VWF, encoded by exons 18-23. Two substitutions in exon 18 of VWF gene, inducing candidate mutations Y795C and C804F were identified in the heterozygous state in two French patients who also displayed the frequent R854Q mutation in exon 20. Expression studies in Cos-7 cells showed that these abnormalities, which implicate cysteine residues, induced secretion, multimerization and FVIII binding defects of corresponding recombinant VWF. Results from transfection experiments with R854Q, performed to reproduce the hybrid VWF present in patient plasma, were in agreement with those obtained for patient's plasma VWF. These findings confirm the importance of the VWF D' domain in FVIII binding. In addition, this work shows that exon 18 should preferentially be sequenced in type 2N VWD patients when the frequent R854Q mutation in exon 20 has been excluded or detected in the heterozygous state.
LFB, Lille, France. hilbert@lfb.fr
L
L
Hilbert
S
S
Jorieux
M
M
Fontenay-Roupie
M
M
Guicheteau
E
E
Fressinaud
D
D
Meyer
C
C
Mazurier
D000328:Adult; D001665:Binding Sites; D005091:Exons; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D020125:Mutation, Missense; D017422:Sequence Analysis, DNA; D014842:von Willebrand Diseases / Q000097:blood* / Q000378:metabolism; D014841:von Willebrand Factor / Q000235:genetics*
D014841:von Willebrand Factor; D005169:Factor VIII